Picture of KALA BIO logo

KALA — KALA BIO News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Kala Bio Inc Expected To Post A Loss Of $4.40 A Share: Earnings Preview

* KALA BIO Inc  KALA.OQ   KALA.O  is expected to show no
change in
quarterly revenue when it reports  results on August 2
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for KALA BIO Inc is for a
loss of
$4.40 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for KALA BIO
Inc is
$16.50​, above​ its last closing price of $6.47. ​​​

This summary was machine generated July 31 at 15:13 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on KALA BIO

See all news